FDA Strengthens Kidney Warnings on J&J, AZ Diabetes Meds
The FDA has revised the warning labels on Johnson & Johnson’s Invokana and AstraZeneca’s Farxiga.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Canagliflozin | Diabetes | Endocrinology | Invokana | Pharmaceuticals | Urology & Nephrology | Warnings